Table 4 Participant characteristics and admission results of clinical measures
Characteristic | RobottDCS | RobottDCS-Sham | Overall |
|---|---|---|---|
Participants (n [%]) | 41 [50.0%] | 41 [50.0%] | 82 [100.0%] |
Age (mean years, [range]) | 66.4 [42–87] | 69.2 [42–90] | 67.8 [42–90] |
Days from stroke to start of trial (mean days [range]) | 1475.2 [226–6935] | 1160.0 [151–6936] | 1317.6 [151–6936] |
Gender (n Female [%]) | 16 [39.0%] | 16 [39.0%] | 32 [39.0%] |
Stroke location (n cortical [%]) | 26 [63.4%] | 27 [65.9%] | 53 [64.6%] |
FMA-UE (mean [range]) | 25.6 [7–57] | 25.4 [7–55] | 25.5 [7–57] |
WMFT (mean [range]) | 60.0 [1–169] | 56.0 [0–167] | 58.0 [0–169] |
BI (mean [range]) | 88.4 [10–100] | 85.0 [15–100] | 86.7 [10–100] |
MRC (mean [range]) | 46.8 [8–79.5] | 44.1 [15–85] | 45.5 [8–85] |